Phosphatidylinositol inhibits respiratory syncytial virus infection

Journal of Lipid Research

Volumn 56, Issue 3, 2015, Pages 578-587

  Numata, Mari ^a   Kandasamy, Pitchaimani ^a   Nagashima, Yoji ^b,d   Fickes, Rachel ^a   Murphy, Robert C ^c   Voelker, Dennis R ^a  

^a DEPARTMENT OF MEDICINE   (United States)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c UNIVERSITY OF COLORADO   (United States)

^d TOKYO WOMEN S MEDICAL UNIVERSITY MEDICAL CENTER EAST   (Japan)

Author keywords

, prophylaxis; Epithelium; Immunology; Infl ammation; Innate immunity; Lung; Phospholipids; Pulmonary surfactant

Indexed keywords

INTERLEUKIN 8; PHOSPHATIDYLINOSITOL; PLACEBO;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CELL COMPARTMENTALIZATION; CELL DISRUPTION; CELL SURFACE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BINDING; DRUG TARGETING; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INOCULATION; INTRINSIC ACTIVITY; LUNG ALVEOLUS CELL; MOUSE; MOUSE MODEL; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS LOAD; ANIMAL; CELL LINE; DRUG EFFECTS; IMMUNOLOGY; LUNG; PATHOLOGY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

ANIMALS; CELL LINE; HUMANS; IMMUNITY, INNATE; LUNG; MICE; PHOSPHATIDYLINOSITOLS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 84924574512     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M055723     Document Type: Article

References (36)

1. Hall, C. B. 2001 . Respiratory syncytial virus and parainfl uenza virus. N. Engl. J. Med. 344 : 1917-1928 .
2. Falsey, A. R. 2007 . Respiratory syncytial virus infection in adults. Semin. Respir. Crit. Care Med. 28 : 171-181 .
3. Falsey, A. R., M. A. Formica, P. A. Hennessey, M. M. Criddle, W. M. Sullender, and E. E. Walsh . 2006 . Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173 : 639-643 .
4. Falsey, A. R., P. A. Hennessey, M. A. Formica, C. Cox, and E. E. Walsh . 2005 . Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 352 : 1749-1759 .
5. Nicholson, K. G., J. Kent, and D. C. Ireland . 1993 . Respiratory viruses and exacerbations of asthma in adults. Br. Med. J . 307 : 982-986 .
6. Teichtahl, H., N. Buckmaster, and E. Pertnikovs . 1997 . The incidence of respiratory tract infection in adults requiring hospitalization for asthma. Chest . 112 : 591-596 .
7. Whimbey, E., and S. Ghosh . 2000 . Respiratory syncytial virus infections in immunocompromised adults. Curr. Clin. Top. Infect. Dis. 20 : 232-255 .
8. Nair, H., D. J. Nokes, B. D. Gessner, M. Dherani, S. A. Madhi, R. J. Singleton, K. L. O'Brien, A. Roca, P. F. Wright, N. Bruce, et al . 2010 . Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet . 375 : 1545-1555 .
9. Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, et al . 2012 . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet . 380 : 2095-2128 .
10. Wright, J. R. 2005 . Immunoregulatory functions of surfactant proteins. Nat. Rev. Immunol. 5 : 58-68 .
11. Numata, M., H. W. Chu, A. Dakhama, and D. R. Voelker . 2010 . Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced infl ammation and infection. Proc. Natl. Acad. Sci. USA . 107 : 320-325 .
12. Numata, M., P. Kandasamy, Y. Nagashima, J. Posey, K. Hartshorn, D. Woodland, and D. R. Voelker . 2012 . Phosphatidylglycerol suppresses infl uenza A virus infection. Am. J. Respir. Cell Mol. Biol. 46 : 479-487 .
13. Numata, M., Y. V. Grinkova, J. R. Mitchell, H. W. Chu, S. G. Sligar, and D. R. Voelker . 2013 . Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung. Int. J. Nanomedicine . 8 : 1417-1427 .
14. Kuronuma, K., H. Mitsuzawa, K. Takeda, C. Nishitani, E. D. Chan, Y. Kuroki, M. Nakamura, and D. R. Voelker . 2009 . Anionic pulmonary surfactant phospholipids inhibit infl ammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J. Biol. Chem. 284 : 25488-25500 .
15. Kandasamy, P., S. Zarini, E. D. Chan, C. C. Leslie, R. C. Murphy, and D. R. Voelker . 2011 . Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages. J. Biol. Chem. 286 : 7841-7853 .
16. Wright S. M., P. M. Hockey, G. Enhorning, P. Strong, K. B. Reid, S. T. Holgate, R. Djukanovic, and A. D. Postle . 2000 . Altered airway surfactant phospholipid composition and reduced lung function in asthma. J. Appl. Physiol. 89 : 1283-1292 .
17. Mueller, M., K. Brandenburg, R. Dedrick, A. B. Schromm, and U. Seydel . 2005 . Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J. Immunol. 174 : 1091-1096 .
18. Wang, P. Y., R. L. Kitchens, and R. S. Munford . 1998 . Phosphatidylinositides bind to plasma membrane CD14 and can prevent monocyte activation by bacterial lipopolysaccharide. J. Biol. Chem. 273 : 24309-24313 .
19. Dakhama, A., Y-M. Lee, and E. W. Gelfand . 2005 . Virus-induced airway dysfunction: pathogenesis and biomechanisms. Pediatr. Infect. Dis. J. 24 : S159-S169 .
20. LeVine, A. M., J. Elliott, J. A. Whitsett, A. Srikiatkhachorn, E. Crouch, N. DeSilva, and T. Korfhagen . 2004 . Surfactant protein-D enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 31 : 193-199 .
21. McKimm-Breschkin, J. L. 2004 . A simplifi ed plaque assay for respiratory syncytial virus-direct visualization of plaques without immunostaining. J. Virol. Methods . 120 : 113-117 .
22. Numata, M., Y. Nagashima, M. L. Moore, K. Z. Berry, M. Chan, P. Kandasamy, R. S. Peebles, Jr ., R. C. Murphy, and D. R. Voelker . 2013 . Phosphatidylglycerol provides short-term prophylaxis against respiratory syncytial virus infection. J. Lipid Res. 54 : 2133-2143 .
23. Cimolai, N., G. P. Taylor, D. Mah, and B. J. Morrison . 1992 . Defi nition and application of a histopathological scoring scheme for an animal model of acute Mycoplasma pneumoniae pulmonary infection. Microbiol. Immunol. 36 : 465-478 .
24. Bligh, E. G., and W. J. Dyer . 1959 . A rapid method of total lipid extraction and purifi cation. Can. J. Biochem. Physiol. 37 : 911-917 .
25. Rouser, G., A. N. Siakatos, and S. Fleischer . 1966 . Quantitative analysis of phospholipids by thin layer chromatography and phosphorous analysis of spots. Lipids . 1 : 85-86 .
26. Chiba, H., S. Pattanajitvilai, A. J. Evans, R. J. Harbeck, and D. R. Voelker . 2002 . Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affi nity interactions with lipids. J. Biol. Chem. 277 : 20379-20385 .
27. Numata, M., P. Kandasamy, and D. R. Voelker . 2012 . Anionic pulmonary surfactant lipid regulation of innate immunity. Expert Rev. Respir. Med. 6 : 243-246 .
28. Erpenbeck, V. J., D. C. Malherbe, S. Sommer, A. Schmiedl, W. Steinhilber, A. J. Ghio, N. Krug, J. R. Wright, and J. M. Hohlfeld . 2005 . Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am. J. Physiol. Lung Cell. Mol. Physiol. 288 : L692-L698 .
29. Lewis, J. F., and A. H. Jobe . 1993 . Surfactant and the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 147 : 218-233 .
30. Schmidt, R., U. Meier, P. Markart, F. Grimminger, H. G. Velcovsky, H. Morr, W. Seeger, and A. Gunther . 2002 . Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol. 283 : L1079-L1085 .
31. Hashimoto, M., Y. Asai, and T. Ogawa . 2003 . Treponemal phospholipids inhibit innate immune responses induced by pathogenassociated molecular patterns. J. Biol. Chem. 278 : 44205-44213 .
32. Hallak, L. K., P. L. Collins, W. Knudson, and M. E. Peeples . 2000 . Iduronic acid-containing glycosaminoglycans on target cells are required for effi cient respiratory syncytial virus infection. Virology . 271 : 264-275 .
33. Tripp, R. A., L. P. Jones, L. M. Haynes, H. Zheng, P. M. Murphy, and L. J. Anderson . 2001 . CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat. Immunol. 2 : 732-738 .
34. Marr, N., and S. E. Turvey . 2012 . Role of human TLR4 in respiratory syncytial virus-induced NF-κ B activation, viral entry and replication . Innate Immun. 18 : 856-865 .
35. Tayyari, F., D. Marchant, T. J. Moraes, W. Duan, P. Mastrangelo, and R. G. Hegele . 2011 . Identifi cation of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17 : 1132-1135 .
36. Hallman, M., T. A. Merritt, and K. Bry . 1994 . The fate of exogenous surfactant in neonates with respiratory distress syndrome . Clin. Pharmacokinet. 26 : 215-232 .